Larotrectinib in non-CNS TRK fusion cancer patients: Outcomes by prior therapy and performance status Meeting Abstract
| Authors: | Drilon, A.; Shen, L.; van Tilburg, C. M.; Tan, D. S. W.; Kummar, S.; Lin, J. J.; Doz, F.; McDermott, R.; Albert, C. M.; Berlin, J.; Bielack, S.; Lassen, U. N.; Tahara, M.; Norenberg, R.; Fellous, M.; Nogai, H.; Xu, R.; Laetsch, T. W.; Hong, D. S. |
| Abstract Title: | Larotrectinib in non-CNS TRK fusion cancer patients: Outcomes by prior therapy and performance status |
| Meeting Title: | ESMO Congress 2021 |
| Journal Title: | Annals of Oncology |
| Volume: | 32 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2021 Sep 16-21 |
| Meeting Location: | Virtual |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2021-09-01 |
| Start Page: | S599 |
| End Page: | S600 |
| Language: | English |
| ACCESSION: | WOS:000700527700510 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.annonc.2021.08.1056 |
| Notes: | Meeting Abstract: 534P -- Source: Wos |
